Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
242.50    0.00 (0.00%)
Bid:
235.00
Ask:
250.00
Spread: 15.00 (6.383%)
Market Cap: £87.20m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Result of AGM

26 Oct 2023 12:34

RNS Number : 4377R
Alumasc Group PLC
26 October 2023

26 October 2023

The Alumasc Group plc

("Alumasc", "Group" or the "Company")

RESULTS OF AGM

Alumasc, the premium building products, systems and solutions group, announces that at the Annual General Meeting held earlier today at Wade, Third Avenue, Halstead, Essex CO9 2SX all resolutions put to shareholders were duly passed.

The results of the meeting on a poll were as follows:

VOTES

FOR

% OF

VOTES

FOR

VOTES

AGAINST

% OF

VOTES

AGAINST

VOTES

WITHHELD

TOTAL VOTES

1

To receive the reports of the Directors and Auditor and the accounts for the year ended 30 June 2023

17,555,202

99.98%

4,042

0.02%

19,041

17,559,244

2

To receive the report of the Remuneration Committee for the year ended 30 June 2023

17,398,132

99.58%

74,131

0.42%

106,022

17,472,263

3

To approve the Remuneration Policy

17,389,521

99.53%

82,985

0.47%

105,779

17,472,506

4

To declare a final dividend of 6.9 pence per share

17,576,285

100.00%

0

0.00%

2,000

17,576,285

5

To re-elect Gilbert Jackson as a Director

17,462,631

99.96%

7,234

0.04%

108,420

17,469,865

6

To re- elect Michael Leaf as a Director

17,462,958

99.96%

6,907

0.04%

108,420

17,469,865

7

To re-appoint Crowe U.K. LLP as Auditor of the Company to hold office until the conclusion of the next AGM

17,547,760

99.85%

26,433

0.15%

4,092

17,574,193

8

That the Audit Committee be authorised to determine the Auditor's remuneration

17,546,184

99.89%

19,609

0.11%

12,492

17,565,793

9

To authorise the renewal of Directors' authorities to allot shares

17,497,535

99.54%

80,241

0.46%

509

17,577,776

10

To authorise the Directors to disapply pre-emption rights: General (special resolution)

17,135,008

98.61%

241,805

1.39%

201,472

17,376,813

11

To authorise the disapplication of statutory pre-emption rights:

Acquisition or capital investment (special resolution)

17,141,484

98.65%

235,329

1.35%

201,472

17,376,813

12

To authorise the Company's authority to purchase its own shares (special resolution)

17,231,650

99.83%

29,726

0.17%

316,909

17,261,376

Notes:

1. A vote 'withheld' is not a vote in English Law and not counted in the calculation of votes cast 'for' or 'against' a resolution.

ENDS

Enquiries:

The Alumasc Group plc

Paul Hooper (Chief Executive)

+44 (0) 1536 383844

Simon Dray (Group Finance Director)

+44 (0) 1536 383844

Helen Ashton (Group Company Secretary)

+44 (0) 1536 383812

Cavendish Capital Markets Ltd (Nominated Adviser)

+44 (0) 207 220 0500

Julian Blunt

Edward Whiley

Peel Hunt LLP (Broker)

+44 (0) 207 418 8831

Mike Bell

Ed Allsopp

Camarco (Financial PR)

Ginny Pulbrook

+44 (0) 203 757 4992

Rosie Driscoll

+44 (0) 203 757 4981

email: alumasc@camarco.co.uk

The Alumasc Group plcBurton Latimer, Kettering, Northants NN15 5JP

LEI: 2138002MV11VKZFJ4359

About Alumasc:

Alumasc is a UK-based supplier of premium building products, systems and solutions. Almost 80% of group sales are driven by building regulations and specifications (developers/housebuilders, architects and structural engineers) because of the performance characteristics offered.

The Group has three business segments with strong positions and brands in their individual markets. The three segments are: Building Envelope; Water Management; and Housebuilding Products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGMFBBTMTJTBTJ
Date   Source Headline
15th Jun 20267:00 amRNSChange of Company Secretary
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.